Search research articles
Contact Us
Filters
Showing results (721-730 of 752) with videos related to
Page
of 76
Sort By:
Nanoscale
|
August 12, 2016
Correlation of nanoscale behaviour of forces and macroscale surface wettability
Abhimanyu Rana, Abhijeet Patra, Meenakshi Annamalai, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
June 2, 2018
EGFR L792H and G796R: Two Novel Mutations Mediating Resistance to the Third-Generation EGFR Tyrosine Kinase Inhibitor Osimertinib
Qi Zhang, Xu-Chao Zhang, Jin-Ji Yang, et al.
NPJ Precision Oncology
|
September 19, 2022
Induction immune-checkpoint inhibitors for resectable oncogene-mutant NSCLC: A multicenter pooled analysis
Chao Zhang, Hua-Fei Chen, Shi Yan, et al.
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy
|
October 6, 2022
Monitoring tumour resistance to the BRAF inhibitor combination regimen in colorectal cancer patients via circulating tumour DNA
Liu-Fang Ye, Zi-Yao Huang, Xiao-Xi Chen, et al.
European Journal of Cancer (Oxford, England : 1990)
|
August 8, 2022
First-in-human phase I study of TQ-B3139 (CT-711) in advanced non-small cell lung cancer patients with ALK and ROS1 rearrangements
Yuxiang Ma, Hongyun Zhao, Jinhui Xue, et al.
Genomics, Proteomics & Bioinformatics
|
April 4, 2025
Cell-free DNA Fragmentomics Assay to Discriminate the Malignancy of Breast Nodules and Evaluate Treatment Response
Jiaqi Liu, Yalun Li, Wanxiangfu Tang, et al.
Cell Reports. Medicine
|
January 31, 2026
A pan-cancer single-cell transcriptomic atlas of human bone metastases
Shuoer Wang, Fen Ma, Dongliang Wang, et al.
Journal for Immunotherapy of Cancer
|
November 11, 2020
Camrelizumab plus gemcitabine and oxaliplatin (GEMOX) in patients with advanced biliary tract cancer: a single-arm, open-label, phase II trial
Xiaofeng Chen, Xiaofeng Wu, Hao Wu, et al.
BMC Medicine
|
July 22, 2025
Multi-omics analysis uncovers predictive biomarkers for the efficacy and outcomes of chemoimmunotherapy in advanced unresectable biliary tract cancers
Jiaojiao Ni, Chaoqun Li, Xiaoqing Xu, et al.
Nature Materials
|
October 10, 2018
Polarity governs atomic interaction through two-dimensional materials
Wei Kong, Huashan Li, Kuan Qiao, et al.
Page
of 76
Search research articles
Search
Showing results (721-730 of 752) with videos related to
Sort By:
Page
of 76
Nanoscale
|
August 12, 2016
Correlation of nanoscale behaviour of forces and macroscale surface wettability
Abhimanyu Rana, Abhijeet Patra, Meenakshi Annamalai, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
June 2, 2018
EGFR L792H and G796R: Two Novel Mutations Mediating Resistance to the Third-Generation EGFR Tyrosine Kinase Inhibitor Osimertinib
Qi Zhang, Xu-Chao Zhang, Jin-Ji Yang, et al.
NPJ Precision Oncology
|
September 19, 2022
Induction immune-checkpoint inhibitors for resectable oncogene-mutant NSCLC: A multicenter pooled analysis
Chao Zhang, Hua-Fei Chen, Shi Yan, et al.
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy
|
October 6, 2022
Monitoring tumour resistance to the BRAF inhibitor combination regimen in colorectal cancer patients via circulating tumour DNA
Liu-Fang Ye, Zi-Yao Huang, Xiao-Xi Chen, et al.
European Journal of Cancer (Oxford, England : 1990)
|
August 8, 2022
First-in-human phase I study of TQ-B3139 (CT-711) in advanced non-small cell lung cancer patients with ALK and ROS1 rearrangements
Yuxiang Ma, Hongyun Zhao, Jinhui Xue, et al.
Genomics, Proteomics & Bioinformatics
|
April 4, 2025
Cell-free DNA Fragmentomics Assay to Discriminate the Malignancy of Breast Nodules and Evaluate Treatment Response
Jiaqi Liu, Yalun Li, Wanxiangfu Tang, et al.
Cell Reports. Medicine
|
January 31, 2026
A pan-cancer single-cell transcriptomic atlas of human bone metastases
Shuoer Wang, Fen Ma, Dongliang Wang, et al.
Journal for Immunotherapy of Cancer
|
November 11, 2020
Camrelizumab plus gemcitabine and oxaliplatin (GEMOX) in patients with advanced biliary tract cancer: a single-arm, open-label, phase II trial
Xiaofeng Chen, Xiaofeng Wu, Hao Wu, et al.
BMC Medicine
|
July 22, 2025
Multi-omics analysis uncovers predictive biomarkers for the efficacy and outcomes of chemoimmunotherapy in advanced unresectable biliary tract cancers
Jiaojiao Ni, Chaoqun Li, Xiaoqing Xu, et al.
Nature Materials
|
October 10, 2018
Polarity governs atomic interaction through two-dimensional materials
Wei Kong, Huashan Li, Kuan Qiao, et al.
Page
of 76